Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$27,937,324
-$1,240,916 QoQ
Shares Held
111,021
-17.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#506
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $207,269,806 across 16 Drug Manufacturers - General names. ABBV ranks #3 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,467 | $66,528,789 | |
| 2 | JNJ |
Johnson & Johnson
|
234,177 | $59,473,932 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
111,021 | $27,937,324 | |
| 4 | AMGN |
Amgen Inc
|
40,211 | $14,561,207 | |
| 5 | MRK |
Merck & Co., Inc.
|
112,376 | $14,440,316 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
128,389 | $7,397,774 | |
| 7 | PFE |
Pfizer Inc
|
197,145 | $4,747,251 | |
| 8 | NVS |
Novartis AG
|
25,239 | $3,955,456 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,937,324 | 111,021 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $29,178,240 | 134,159 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $23,251,599 | 101,762 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $23,482,555 | 101,419 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $19,018,996 | 102,462 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $20,885,582 | 99,683 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $17,782,972 | 100,073 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $19,838,248 | 100,457 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,887,173 | 98,456 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,759,649 | 53,595 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,404,178 | 54,231 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $10,274,407 | 68,928 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $7,088,145 | 52,610 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $7,425,526 | 46,593 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $7,382,668 | 45,682 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,401,145 | 47,695 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $9,396,366 | 61,350 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,877,038 | 60,928 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $8,148,642 | 60,182 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,227,442 | 57,731 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,112,071 | 54,262 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,809,790 | 53,685 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,161,201 | 48,168 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,352,770 | 38,278 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,682,437 | 37,507 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,032,215 | 26,673 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||